Led by BioNTech, six biotechs line up for October IPOs
October: The season of swirling red leaves, Jack-o-lanterns, postseason baseball and this year, a fresh harvest of six biotech IPOs ripe with clinical-stage drugs, trying …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
